Discover 440 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Rochester has a wide variety of active clinical trials, focusing on conditions such as kidney disease, cancer, and cardiovascular disorders. Participants in these studies have the opportunity to explore emerging treatments in the city’s leading research institutions, both as healthy volunteers in paid trials and as individuals looking for studies targeting specific health conditions.
Filter
2
Filter results
Results: 440
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Rochester NY, Arlington VA, Richmond VA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase 2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Rochester NY, Buffalo NY, Albany NY, Camp Hill PA,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
Gastroschisis Outcomes of Delivery (GOOD) Study
for
Gastroschisis
Location: Rochester NY, Cleveland OH, New York NY, Wilmington DE,
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
for
Congenital Myotonic Dystrophy, CDM
Location: Rochester NY, Richmond VA, Fairway KS, Los Angeles CA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 0 - 4
Code: NCT05224778
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer